FIELD: medicine.
SUBSTANCE: invention is based on measurement of the mtDNA heteroplasmy degree by 652ins/delG, A750G, A1555G, C3256T, T3336C, C5178A, 8516insA/C/AC, 8528insA, 8930insG, G9477A, 10958insC, A12308G, G12372A, 13047insC, 13050insC, C14766T, G15059A and A15326G mutations. The measured indices of heteroplasmy are used as variables in the formula by which the degree of the total mutational load of the mitochondrial genome is calculated. If the threshold value of this parameter which is 40.3 points is exceeded, atherosclerosis and individual genetic predisposition to atherosclerosis, ischemic heart disease and myocardial infarction are diagnosed.
EFFECT: 1 cl.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINATION OF GENETIC PREDISPOSITION TO ATHEROSCLEROSIS, ISCHEMIC HEART DISEASE AND MYOCARDIAL INFARCTION | 2016 |
|
RU2641568C1 |
| METHOD FOR PREDICTION OF MULTIFOCAL ATHEROSCLEROTIC INVOLVEMENT | 2018 |
|
RU2704224C1 |
| METHOD FOR ASSESSING GENETIC RISK OF ATHEROSCLEROSIS BASED ON DETERMINATION OF MITOCHONDRIAL GENOME VERSIONS | 2015 |
|
RU2592233C1 |
| METHOD FOR PREDICTION OF ATHEROSCLEROSIS DEVELOPMENT | 2018 |
|
RU2704960C1 |
| METHOD OF DETERMINING DEGREE OF HETEROPLASMY MUTATIONS OF MITOCHONDRIAL GENOME | 2015 |
|
RU2600023C1 |
| METHOD FOR LIABILITY TO DEVELOPMENT OF ATHEROSCLEROSIS IN MIDDLE-AGED MEN | 2020 |
|
RU2738975C1 |
| METHOD FOR MOLECULAR DIAGNOSTICS OF MITOCHONDRIAL PATHOLOGIES BASED ON PYROSEQUENCING TECHNOLOGY | 2015 |
|
RU2633752C2 |
| METHOD FOR PREDICTING MULTIPLE ORGAN FAILURE AFTER HEART SURGERY PERFORMED UNDER CONDITIONS OF ARTIFICIAL BLOOD CIRCULATION | 2020 |
|
RU2753589C1 |
| METHOD FOR PREDICTION OF ACUTE MYOCARDIAL ISCHEMIA OUTCOME | 2016 |
|
RU2649774C1 |
| METHOD DEFINING MUTATIONS OF GENE MTRNR1 AT ACUTE PERCEPTIVE HEARING LOSS CAUSED BY USAGE OF ANTIBIOTICS FROM GROUP OF AMINOGLYCOSIDES | 2007 |
|
RU2335541C1 |
